Cassava Sciences, Inc. (SAVA)

Cassava Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	16.53	11.99	8.06	3.74	3.39
Research & Development	89.42	68.03	24.81	3.05	1.57
Other Operating Expenses	0	0	0	-0.35	0
Operating Expenses	105.96	80.02	32.87	6.45	4.96
Operating Income	-105.96	-80.02	-32.87	-6.45	-4.96
Other Expense / Income	-8.74	-3.77	-0.48	-0.11	-0.33
Pretax Income	-97.22	-76.25	-32.39	-6.33	-4.63
Net Income	-97.22	-76.25	-32.39	-6.33	-4.63
Shares Outstanding (Basic)	42	40	39	26	17
Shares Outstanding (Diluted)	42	40	39	26	17
Shares Change	4.30%	2.02%	50.95%	49.93%	63.00%
EPS (Basic)	-2.32	-1.90	-0.82	-0.24	-0.27
EPS (Diluted)	-2.32	-1.90	-0.82	-0.24	-0.27
Free Cash Flow	-82.44	-80.23	-52.41	-5.02	-2.53
Free Cash Flow Per Share	-1.97	-2.00	-1.33	-0.19	-0.14
EBITDA	-95.69	-74.95	-31.85	-6.31	-4.57
Depreciation & Amortization	1.53	1.3	0.53	0.02	0.06
EBIT	-97.22	-76.25	-32.39	-6.33	-4.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).